WELL Health Technologies (TSE:WELL) Issues Quarterly Earnings Results

WELL Health Technologies (TSE:WELL) released its earnings results on Thursday. The company reported C$0.20 EPS for the quarter, FiscalAI reports. WELL Health Technologies had a negative net margin of 3.58% and a negative return on equity of 5.13%. The company had revenue of C$384.77 million for the quarter.

Here are the key takeaways from WELL Health Technologies’ conference call:

• Record 2025 financials: Revenue of CAD 1.4B (+52% YoY), Adjusted EBITDA of CAD 203.7M (14.5% margin) and Adjusted Net Income of CAD 126.5M, with free cash flow to shareholders of CAD 58.2M.
• Underlying (normalized) growth: Excluding Circle Medical and CRH impacts, 2025 normalized revenue was CAD 1.35B, normalized Adjusted EBITDA was CAD 148.6M (+17% YoY) and normalized adjusted net income was CAD 99M (+102%).
• Technology momentum: WELLSTAR reached ARR of CAD 72.6M (revenue CAD 72.9M, +63%) and HEALWELL AI contributed CAD 112.9M in 2025 with improving profitability and recent enterprise wins including a multimillion-dollar U.S. statewide HIE contract.
• Scale and M&A runway in Canada: WELL operates 252 clinics (4.3M Canadian visits, +37%), ~1,400 physicians, ~CAD 260M revenue under LOI (broader CAD 455M+ pipeline) and expanded its senior secured credit facility to CAD 400M to fund further acquisitions.
• U.S. asset strategic review and resolution progress: Active sale processes for WISP, Circle Medical and CRH, an agreement in principle with the DOJ for Circle Medical (provision updated to CAD 3.3M) and partial re‑recognition of CRH revenue after the cyber incident, but timing and value realization remain uncertain.

WELL Health Technologies Stock Down 0.5%

Shares of WELL opened at C$4.19 on Friday. The business’s 50 day moving average is C$4.11 and its 200 day moving average is C$4.38. The company has a current ratio of 0.92, a quick ratio of 1.02 and a debt-to-equity ratio of 73.92. WELL Health Technologies has a 12-month low of C$3.58 and a 12-month high of C$6.08. The company has a market capitalization of C$1.06 billion, a PE ratio of -46.56, a price-to-earnings-growth ratio of -1.93 and a beta of 0.85.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on WELL. Scotiabank reduced their price objective on shares of WELL Health Technologies from C$7.00 to C$6.50 and set an “outperform” rating for the company in a research note on Wednesday, February 4th. Canadian Imperial Bank of Commerce upgraded shares of WELL Health Technologies from a “neutral” rating to an “outperform” rating in a research note on Wednesday, December 3rd. Six research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of C$7.35.

WELL Health Technologies Company Profile

WELL Health Technologies Corp is the owner and operator of a portfolio of Primary Hclinics delivering healthcare-related services It operates through below segments: clinical operations and allied health, Electronic medical record (EMR), Billing and revenue cycle management solutions, Digital apps, Cybersecurity, CRH, MyHealth, and corporate/shared services. Its segments are grouped in three divisions; Omni-channel Patient Services – Primary includes clinical operations and allied health. Omni-channel Patient Services – Specialized comprises CRH and MyHealth under two segments.